216 related articles for article (PubMed ID: 7757362)
1. [Immune bacteriolysis reaction in the assessment of immunological effectiveness of serogroup B meningococcal vaccine].
Golovina LI; Kuvakina VI; Alliluev AP; Basnak'ian IA; Sivko RI
Klin Lab Diagn; 1995; (1):26-9. PubMed ID: 7757362
[TBL] [Abstract][Full Text] [Related]
2. Neisseria meningitidis serogroup C polysaccharide and serogroup B outer membrane vesicle conjugate as a bivalent meningococcus vaccine candidate.
Fukasawa LO; Gorla MC; Schenkman RP; Garcia LR; Carneiro SM; Raw I; Tanizaki MM
Vaccine; 1999 Aug; 17(23-24):2951-8. PubMed ID: 10462229
[TBL] [Abstract][Full Text] [Related]
3. Functional activity of anti-Neisserial surface protein A monoclonal antibodies against strains of Neisseria meningitidis serogroup B.
Moe GR; Zuno-Mitchell P; Lee SS; Lucas AH; Granoff DM
Infect Immun; 2001 Jun; 69(6):3762-71. PubMed ID: 11349041
[TBL] [Abstract][Full Text] [Related]
4. Neisseria meningitidis serogroup B outer membrane vesicle vaccine in adults with occupational risk for meningococcal disease.
Fischer M; Carlone GM; Holst J; Williams D; Stephens DS; Perkins BA
Vaccine; 1999 May; 17(19):2377-83. PubMed ID: 10392619
[TBL] [Abstract][Full Text] [Related]
5. Bactericidal antibody responses of juvenile rhesus monkeys immunized with group B Neisseria meningitidis capsular polysaccharide-protein conjugate vaccines.
Zollinger WD; Moran EE; Devi SJ; Frasch CE
Infect Immun; 1997 Mar; 65(3):1053-60. PubMed ID: 9038315
[TBL] [Abstract][Full Text] [Related]
6. Antibody responses to serogroup B meningococcal outer membrane antigens after vaccination and infection.
Rosenqvist E; Harthug S; Frøholm LO; Høiby EA; Bøvre K; Zollinger WD
J Clin Microbiol; 1988 Aug; 26(8):1543-8. PubMed ID: 3139705
[TBL] [Abstract][Full Text] [Related]
7. [Immunity against Neisseria meningitidis in different population groups].
Pauste Ruiz H; García Imia L; Campa Huergo C; Gutiérrez Hernández M; Valcárcel Novo M
Rev Cubana Med Trop; 1989; 41(1):135-47. PubMed ID: 2505344
[TBL] [Abstract][Full Text] [Related]
8. Immunogenicity and safety testing of a group B intranasal meningococcal native outer membrane vesicle vaccine.
Katial RK; Brandt BL; Moran EE; Marks S; Agnello V; Zollinger WD
Infect Immun; 2002 Feb; 70(2):702-7. PubMed ID: 11796602
[TBL] [Abstract][Full Text] [Related]
9. Serum antibodies to capsular polysaccharide vaccine of group A and C Neisseria meningitidis in military recruits in Italy.
Occhionero M; Usai G; Di Martino M; Le Moli S; Stroffolini T; Mastrantonio P
Allergol Immunopathol (Madr); 1991; 19(1):39-41. PubMed ID: 1950941
[TBL] [Abstract][Full Text] [Related]
10. Immunogenicity of 2 serogroup B outer-membrane protein meningococcal vaccines: a randomized controlled trial in Chile.
Tappero JW; Lagos R; Ballesteros AM; Plikaytis B; Williams D; Dykes J; Gheesling LL; Carlone GM; Høiby EA; Holst J; Nøkleby H; Rosenqvist E; Sierra G; Campa C; Sotolongo F; Vega J; Garcia J; Herrera P; Poolman JT; Perkins BA
JAMA; 1999 Apr; 281(16):1520-7. PubMed ID: 10227322
[TBL] [Abstract][Full Text] [Related]
11. The capsular polysaccharide of group B Neisseria meningitidis as a vehicle for vaccine development.
Jennings HJ
Contrib Microbiol Immunol; 1989; 10():151-65. PubMed ID: 2479499
[No Abstract] [Full Text] [Related]
12. Immunologic priming to capsular polysaccharide in infants immunized with Haemophilus influenzae type b polysaccharide-Neisseria meningitidis outer membrane protein conjugate vaccine.
Weinberg GA; Einhorn MS; Lenoir AA; Granoff PD; Granoff DM
J Pediatr; 1987 Jul; 111(1):22-7. PubMed ID: 3110388
[TBL] [Abstract][Full Text] [Related]
13. Effect of aluminium hydroxide and meningococcal serogroup C capsular polysaccharide on the immunogenicity and reactogenicity of a group B Neisseria meningitidis outer membrane vesicle vaccine.
Rosenqvist E; Høiby EA; Bjune G; Aase A; Halstensen A; Lehmann AK; Paulssen J; Holst J; Michaelsen TE; Nøkleby H; Frøholm LO; Closs O
Dev Biol Stand; 1998; 92():323-33. PubMed ID: 9554288
[TBL] [Abstract][Full Text] [Related]
14. Assessment of the direct effectiveness of BC meningococcal vaccine in Rio de Janeiro, Brazil: a case-control study.
Noronha CP; Struchiner CJ; Halloran ME
Int J Epidemiol; 1995 Oct; 24(5):1050-7. PubMed ID: 8557439
[TBL] [Abstract][Full Text] [Related]
15. Class-specific human bactericidal antibodies to capsular and noncapsular surface antigens of Neisseria meningitidis.
Skevakis L; Frasch CE; Zahradnik JM; Dolin R
J Infect Dis; 1984 Mar; 149(3):387-96. PubMed ID: 6425422
[TBL] [Abstract][Full Text] [Related]
16. Status of a group B Neisseria meningitidis vaccine.
Frasch CE
Eur J Clin Microbiol; 1985 Dec; 4(6):533-6. PubMed ID: 3937731
[No Abstract] [Full Text] [Related]
17. Safety and immunogenicity of a booster dose of meningococcal (groups A, C, W, and Y) polysaccharide diphtheria toxoid conjugate vaccine.
Robertson CA; Greenberg DP; Hedrick J; Pichichero M; Decker MD; Saunders M
Vaccine; 2016 Oct; 34(44):5273-5278. PubMed ID: 27642132
[TBL] [Abstract][Full Text] [Related]
18. [Humoral immune response to the capsular polysaccharide of Neisseria meningitidis serogroup C in an antimeningococcal BC vaccination trial in Antioquia, Colombia].
Echeverry Uribe ML; Malberty Agüero JA; Galeano Marín LA; Sotolongo Padrón FT; Galguera Domínguez MA; Montoya Barrientos CM; Martínez Ruiz O; Nerey MC; Camarasa MA; Bacallao Gallestey J
Bol Oficina Sanit Panam; 1995 Apr; 118(4):295-301. PubMed ID: 7779284
[TBL] [Abstract][Full Text] [Related]
19. Specificity of antibodies to O-acetyl-positive and O-acetyl-negative group C meningococcal polysaccharides in sera from vaccinees and carriers.
Arakere G; Frasch CE
Infect Immun; 1991 Dec; 59(12):4349-56. PubMed ID: 1937795
[TBL] [Abstract][Full Text] [Related]
20. Induction of immunologic memory by conjugated vs plain meningococcal C polysaccharide vaccine in toddlers: a randomized controlled trial.
MacDonald NE; Halperin SA; Law BJ; Forrest B; Danzig LE; Granoff DM
JAMA; 1998 Nov; 280(19):1685-9. PubMed ID: 9832000
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]